Does Humana Cover Metformin?

How Humana Classifies Metformin on Its Formulary

Humana organizes prescription drugs into tiers that determine out-of-pocket costs for members. Metformin hydrochloride immediate-release (IR) tablets appear on Tier 1, the preferred generic tier, across the majority of Humana's 2026 plan documents [1]. This placement reflects metformin's status as the most widely prescribed oral antidiabetic drug in the United States, with over 90 million dispensed prescriptions annually according to ClinCalc data derived from the IQVIA National Prescription Audit [2].

Immediate-Release vs. Extended-Release Tiers

The IR formulation (available in 500 mg, 850 mg, and 1,000 mg tablets) consistently lands on Tier 1. Metformin extended-release (ER) tablets, including brand-name Glucophage XR, may be placed on Tier 2 (generic) or Tier 3 (preferred brand) depending on the specific Humana plan and manufacturer [3]. The FDA lists multiple approved ER generic manufacturers, and Humana's preferred drug list favors the lowest-cost generic version available at network pharmacies [4].

Brand vs. Generic Placement

Brand-name Glucophage has been discontinued in the U.S. Market, but some branded ER products remain. Humana may classify these on Tier 3 or exclude them from the formulary when a therapeutically equivalent generic exists. The American Diabetes Association (ADA) Standards of Care 2024 make no distinction between brand and generic metformin in their treatment algorithms, supporting the use of whichever formulation is most accessible to the patient [5].

What Humana Members Pay for Metformin

Out-of-pocket costs for metformin through Humana depend on the plan type, pharmacy network status, and whether the member has reached the Medicare Part D deductible.

Medicare Advantage and Part D Cost-Sharing

On most Humana Medicare Advantage Prescription Drug (MAPD) plans, Tier 1 copays range from $0 to $10 for a 30-day supply at a preferred retail pharmacy [1]. The Inflation Reduction Act of 2022, signed into law as Public Law 117-169, capped insulin copays at $35 per month for Medicare beneficiaries and expanded $0 generic coverage in the Part D coverage gap [6]. Metformin, as a Tier 1 generic, qualifies for $0 cost-sharing during the coverage gap phase on most Humana Part D plans.

Commercial Plan Cost-Sharing

For employer-sponsored Humana plans, metformin copays typically fall between $3 and $15 depending on the benefit design. Many Humana commercial plans waive the deductible for Tier 1 generics entirely [7]. The National Health Expenditure data from CMS show that generic drugs account for 90% of all prescriptions filled in the U.S. But only 18% of total drug spending, making metformin one of the least expensive chronic medications available [8].

Mail-Order Savings

Humana members can fill 90-day metformin prescriptions through CenterWell Pharmacy (formerly Humana Pharmacy) at reduced cost-sharing. A 90-day mail-order fill typically costs 2 to 2.5 times the 30-day copay rather than 3 times, saving $3 to $10 per quarter for most members [1].

Prior Authorization and Step Therapy Requirements

Metformin does not require prior authorization on any standard Humana formulary. The ADA and the American Association of Clinical Endocrinology (AACE) both recommend metformin as first-line pharmacotherapy for type 2 diabetes, which eliminates any clinical rationale for step therapy restrictions [5][9].

When Prior Authorization Might Apply

Rare exceptions exist. If a prescriber requests a brand-name ER product when a generic is available, Humana may require a coverage exception or prior authorization. Metformin solution (Riomet), an oral liquid formulation, sometimes requires prior authorization because of its significantly higher cost compared to tablets [4].

Quantity Limits

Humana applies standard quantity limits of 90 tablets per 30 days for metformin 500 mg and 60 tablets per 30 days for metformin 1,000 mg. These limits align with the maximum FDA-approved dose of 2,550 mg per day for IR and 2,000 mg per day for ER formulations [3]. Prescribers can request a quantity limit exception through Humana's coverage determination process if clinical need exceeds these thresholds.

Why Metformin Remains a Preferred Drug Across Insurers

Metformin's dominance on preferred formulary tiers is driven by decades of clinical evidence, low cost, and broad guideline endorsement.

Clinical Evidence Base

The United Kingdom Prospective Diabetes Study (UKPDS), which enrolled 5,102 patients with newly diagnosed type 2 diabetes, demonstrated that metformin reduced diabetes-related death by 42% and all-cause mortality by 36% in overweight patients compared to conventional treatment over a median follow-up of 10.7 years [10]. The Diabetes Prevention Program (DPP) trial (N=3,234) showed that metformin 850 mg twice daily reduced the incidence of type 2 diabetes by 31% compared to placebo over 2.8 years in high-risk adults [11].

Guideline Endorsement

The ADA Standards of Care 2024 recommend metformin as the preferred initial pharmacologic agent for type 2 diabetes when lifestyle interventions alone are insufficient [5]. The AACE Comprehensive Diabetes Management Algorithm places metformin as a first-line option alongside SGLT2 inhibitors and GLP-1 receptor agonists, depending on comorbidities [9]. Both guidelines note that metformin's cost-effectiveness profile is unmatched by any other oral antidiabetic agent.

Cost-Effectiveness Data

A 2020 analysis published in Diabetes Care calculated that metformin costs approximately $4 per month at retail pharmacies participating in generic discount programs, making it one of the three least expensive chronic disease medications in the U.S. [12]. The WHO Essential Medicines List includes metformin as a core medicine for diabetes management, reflecting its global value proposition [13].

How to Confirm Your Humana Metformin Coverage

Verifying your specific coverage takes about five minutes and prevents surprises at the pharmacy counter.

Online Formulary Lookup

Humana publishes searchable formularies for every plan at humana.com. Members can log in, manage to "Pharmacy," select "Drug List," and search for metformin to see their tier, copay, and any restrictions. Medicare plan formularies are also available through the CMS Medicare Plan Finder tool at medicare.gov [14].

Calling Humana Member Services

The phone number on the back of the Humana ID card connects members to a pharmacy benefits representative who can confirm metformin coverage, provide exact copay amounts, and identify preferred pharmacies in the member's network. Humana's Medicare member services line is 1-800-457-4708.

Asking Your Pharmacist

Retail pharmacists can run a real-time insurance adjudication to determine the exact copay before dispensing. This "test claim" process shows the Humana-negotiated price, any applicable deductible, and whether the prescription requires prior authorization [7].

Metformin Coverage Under Humana Medicare Part D Specifically

Medicare Part D coverage for metformin deserves separate attention because of recent federal policy changes that directly affect member costs.

The Inflation Reduction Act Impact

Starting in 2025, the Inflation Reduction Act eliminated the Part D coverage gap ("donut hole") entirely for all generic and brand-name drugs [6]. For metformin users on Humana Part D plans, this means consistent Tier 1 copays throughout the benefit year, with no gap-phase cost increase. The Congressional Budget Office estimated that this provision saves Medicare beneficiaries an average of $400 per year across all medications [15].

Low-Income Subsidy (Extra Help) Benefits

Humana Medicare Part D members who qualify for the Low-Income Subsidy (LIS, also called Extra Help) pay $0 for metformin under full LIS benefits or $1.55 to $4.50 per prescription under partial LIS benefits in 2026 [14]. The Social Security Administration processes LIS applications, and eligibility is based on income below 150% of the federal poverty level and limited financial resources.

Catastrophic Coverage Phase

If a Humana Part D member reaches the catastrophic coverage threshold ($2,000 in true out-of-pocket costs for 2026), metformin costs drop to $0 under the Inflation Reduction Act's $2,000 annual out-of-pocket cap [6]. This cap applies to all Part D covered drugs combined.

Metformin for Off-Label Uses and Humana Coverage Implications

Metformin is increasingly prescribed for conditions beyond type 2 diabetes, and coverage may vary based on indication.

Prediabetes and Diabetes Prevention

The DPP trial demonstrated a 31% reduction in diabetes incidence with metformin in adults with prediabetes and a BMI of 24 kg/m² or higher [11]. The ADA recommends considering metformin for diabetes prevention in patients with prediabetes, particularly those with BMI ≥35, age <60, or a history of gestational diabetes [5]. Humana generally covers metformin for prediabetes when the prescriber documents the diagnosis, though some commercial plans may require the ICD-10 code R73.03 (prediabetes) on the claim [7].

Polycystic Ovary Syndrome (PCOS)

Metformin is widely used off-label for PCOS-related insulin resistance and ovulatory dysfunction. The Endocrine Society's 2023 clinical practice guideline on PCOS acknowledges metformin as an adjunctive therapy, particularly for metabolic features [16]. Humana does not restrict metformin coverage by diagnosis code for generic formulations, so PCOS patients filling metformin typically receive standard Tier 1 pricing.

Longevity and Aging Research

The Targeting Aging with Metformin (TAME) trial, led by Dr. Nir Barzilai at the Albert Einstein College of Medicine, is a planned six-year study of 3,000 adults aged 65 to 79 designed to test whether metformin can delay age-related diseases [17]. While this trial has not yet reported results, off-label metformin prescriptions for longevity purposes are growing. Humana will cover metformin regardless of the prescriber's clinical rationale, provided a valid prescription exists and the drug is dispensed as a covered generic [1].

Safety Monitoring While on Metformin

Humana's coverage of metformin includes coverage for the laboratory monitoring required to use the drug safely.

Baseline and Ongoing Labs

The FDA prescribing information for metformin recommends checking serum creatinine and estimated glomerular filtration rate (eGFR) before initiation and at least annually thereafter [3]. Metformin is contraindicated when eGFR falls below 30 mL/min/1.73 m² and should be used with caution at eGFR 30 to 45 mL/min/1.73 m² [3]. Vitamin B12 levels should be monitored periodically, as the ADA notes that metformin use is associated with B12 deficiency in up to 30% of long-term users based on data from the DPP Outcomes Study [18].

Lactic Acidosis Risk

The FDA issued a revised safety communication in 2016 expanding metformin's use to patients with mild-to-moderate renal impairment (eGFR 30 to 60 mL/min/1.73 m²), noting that the historical risk of lactic acidosis was overstated in earlier labeling [4]. A Cochrane systematic review of 347 comparative trials and cohort studies found no cases of fatal or nonfatal lactic acidosis attributable to metformin at therapeutic doses [19]. Humana covers the renal function testing and metabolic panels required for safe metformin monitoring under preventive and diagnostic lab benefits.

Switching to Humana With an Existing Metformin Prescription

Members transitioning to Humana from another insurer can maintain uninterrupted metformin access through several mechanisms.

Transition Supply Policy

CMS requires all Medicare Part D plans, including Humana's, to provide a temporary transition supply of at least 30 days for medications a new member was taking before enrollment [14]. This applies to metformin and ensures no gap in therapy during the transition period. Humana's transition fill policy allows one fill at a network retail pharmacy within the first 90 days of enrollment.

Pharmacy Network Considerations

Humana contracts with over 60,000 retail pharmacies nationwide, including CVS, Walgreens, Walmart, Rite Aid, and most independent pharmacies [1]. Walmart's $4 generic program includes metformin 500 mg and 1,000 mg IR tablets for a 30-day supply, which may be less expensive than the Humana copay for some commercial plan members [7].